Metrics to compare | 363250 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship363250PeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.8x | −5.1x | −0.5x | |
PEG Ratio | 0.07 | −0.20 | 0.00 | |
Price/Book | 3.4x | 2.0x | 2.6x | |
Price / LTM Sales | 49.8x | 4.7x | 3.0x | |
Upside (Analyst Target) | - | 40.1% | 58.6% | |
Fair Value Upside | Unlock | 16.4% | 10.2% | Unlock |
Genesystem Co., Ltd., a biotech engineering company, specializes in molecular testing solutions to target on-site testing needs. The company offers PCR systems, multiplex biochips, and PCR reagents. It also provides human pathogen assays, including novel coronavirus (SARS-CoV-2) detection kits, SARS-CoV-2/Flu/RSV simultaneous detection kits, and mycobacterium tuberculosis detection kits; veterinary diagnostics; food safety assays comprising foodborne pathogen detection kits, HALAL food testing kits, and meat species identification kits; and nucleic acid extraction assays, such as extraction kits, extraction buffers, lysis buffers, and gDNA extraction kits. The company was incorporated in 2010 and is based in Daejeon, South Korea.